Cargando…
Prostate cancer : a multidisciplinary approach to diagnosis and management /
"With an emphasis on multidisciplinary collaboration and decision-making, this practical resource reflects the extraordinary advances in the treatment of prostate cancer during the past five years. Approximately thirty international, leading-edge investigators describe the most current evidence...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , , , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
New York :
DemosMedical,
[2015]
|
| Colección: | Current multidisciplinary oncology.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | EBSCO_ocn898894164 | ||
| 003 | OCoLC | ||
| 005 | 20231017213018.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 141229t20152015nyua ob 001 0 eng d | ||
| 040 | |a N$T |b eng |e rda |e pn |c N$T |d YDXCP |d N$T |d E7B |d OCLCF |d EBLCP |d OCLCO |d MMU |d OCLCO |d OCLCQ |d OCLCO |d D6H |d LVT |d COCUF |d CNNOR |d MOR |d CCO |d PIFAG |d ZCU |d UAB |d AGLDB |d MERUC |d OCLCQ |d OCLCO |d OCLCA |d U3W |d OCLCA |d STF |d OCLCQ |d VTS |d ICG |d VT2 |d OCLCQ |d WYU |d G3B |d OCLCA |d TKN |d OCLCO |d DKC |d OCLCQ |d UKAHL |d OCLCQ |d OCLCA |d AJS |d OCLCO |d OCLCQ |d OCL |d OCLCO | ||
| 019 | |a 899158351 |a 1055395622 |a 1066511003 |a 1081230986 |a 1228551149 | ||
| 020 | |a 9781617051067 |q (electronic bk.) | ||
| 020 | |a 1617051063 |q (electronic bk.) | ||
| 020 | |z 9781936287598 |q (print) | ||
| 020 | |z 1936287595 |q (print) | ||
| 029 | 1 | |a AU@ |b 000056058018 | |
| 029 | 1 | |a DEBBG |b BV042794151 | |
| 029 | 1 | |a DEBBG |b BV044072560 | |
| 029 | 1 | |a DEBSZ |b 493155104 | |
| 029 | 1 | |a DKDLA |b 820120-katalog:999934024005765 | |
| 035 | |a (OCoLC)898894164 |z (OCoLC)899158351 |z (OCoLC)1055395622 |z (OCoLC)1066511003 |z (OCoLC)1081230986 |z (OCoLC)1228551149 | ||
| 050 | 4 | |a RC280.P7 | |
| 060 | 4 | |a WJ 762 | |
| 072 | 7 | |a HEA |x 039030 |2 bisacsh | |
| 072 | 7 | |a MED |x 062000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.99/463 |2 23 |
| 049 | |a UAMI | ||
| 130 | 0 | |a Prostate cancer (Dicker) | |
| 245 | 1 | 0 | |a Prostate cancer : |b a multidisciplinary approach to diagnosis and management / |c edited by Adam P. Dicker, William Kevin Kelly, Nicholas G. Zaorsky, Edouard J. Trabulsi ; illustrations by Nicholas G. Zaorsky. |
| 264 | 1 | |a New York : |b DemosMedical, |c [2015] | |
| 264 | 4 | |c ©2015 | |
| 300 | |a 1 online resource (xxi, 412 pages) : |b illustrations (some color) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Current multidisciplinary oncology series | |
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a Part I: Epidemiology, screening, and diagnosis -- Introduction: the multidisciplinary approach to prostate cancer -- Epidemiology of prostate cancer -- Diet and prostate cancer -- Epidemiology: obesity as a risk factor -- Screening and diagnosis: the pros of PSA screening -- The argument against prostate cancer screening -- How do we improve PSA accuracy? -- Screening and diagnosis: an update on the ISUP-modified Gleason score and its controversies -- Evaluation of distant disease: the utility of nuclear imaging -- Current approaches to prostate cancer staging and risk stratification: in the midst of a paradigm shift -- Novel molecular and genotype profiling in prostate cancer: the future of screening, diagnosis, and staging -- Genomics and risk assessment -- Future direction: novel urine and serum markers -- Morphometric and systems pathology: the future of screening, diagnosis, and staging -- PET: the future of screening, diagnosis, and staging for prostate cancer -- DCE MRI and MR spectroscopy: the future of screening, diagnosis, and staging -- Future direction: contrast ultrasound -- Counseling patients with clinically localized, high-risk prostate cancer -- Part II: Treatment for low-risk, localized disease -- Active surveillance for prostate cancer: an overview -- Treatment of low-risk, localized prostate cancer: a holistic approach with diet -- Traditional radical prostatectomy -- Laparoscopic radical prostatectomy: techniques and complications -- Robotic radical prostatectomy: the Thomas Jefferson University experience -- Surgical training, digital capture, virtual reality, and the future of radical prostatectomy -- External beam radiation therapy: conventional fractionation -- Hypofractionated radiation therapy for localized prostate cancer -- Stereotactic body radiation therapy for localized prostate cancer -- Treatment of low-risk, localized prostate cancer: use of proton therapy -- Treatment of low-risk, localized prostate cancer: brachytherapy -- Treatment of low-risk, localized prostate cancer: general principles of ablative and focal therapies -- Hyperthermia for prostate cancer -- Ablative techniques: vascular targeted photodynamic therapy -- Laser ablative techniques for prostate cancer -- Irreversible electroporation (IRE) prostate ablation -- Quality of life with surgery -- Quality of life with androgen deprivation therapy -- Quality of life with external beam radiation therapy -- Quality of life with brachytherapy for low-risk localized prostate cancer -- Role for comparative effectiveness research in treatment decision making -- Defining treatment failure for localized prostate cancer: PSA and beyond -- Prognosis after biochemical failure and surrogate endpoints for prostate cancer-specific mortality -- Part III: Treatment for high-risk, localized, and locally advanced disease -- treatment of high-risk prostate cancer: the role of low-dose rate (LDR) and high-dose rate (HDR) brachytherapy -- Part IV: Treatment of disseminated disease -- Salvage therapy for rising PSA -- Metastatic hormone sensitive prostate cancer -- Metastatic castrate-resistant prostate cancer: mechanisms of hormone escape -- Metastatic castrate-resistant prostate cancer: role of chemotherapy and multifaceted treatment paradigms -- Metastatic castrate-resistant prostate cancer: role of androgen signaling inhibitors -- Radiation and the immune system -- Immunotherapy: agents targeting prostate cancer -- Treatment of bony metastases: inhibitors of bone resorption -- Treatment of bone metastases: radiopharmaceuticals -- Prognostication of metastatic castration-resistant prostate cancer. | |
| 520 | |a "With an emphasis on multidisciplinary collaboration and decision-making, this practical resource reflects the extraordinary advances in the treatment of prostate cancer during the past five years. Approximately thirty international, leading-edge investigators describe the most current evidence-based approaches to prostate cancer treatment. The book provides a comprehensive view of the entire spectrum of prostate cancer management from initial screening through novel and experimental treatments that have the potential for a major impact on practice"--Publisher's description | ||
| 588 | 0 | |a Online resource; title from resource home page (ebrary, viewed November 2, 2015). | |
| 590 | |a eBooks on EBSCOhost |b EBSCO eBook Subscription Academic Collection - Worldwide | ||
| 650 | 0 | |a Prostate |x Cancer |x Diagnosis. | |
| 650 | 0 | |a Prostate |x Cancer |x Treatment. | |
| 650 | 0 | |a Health care teams. | |
| 650 | 0 | |a Prognosis. | |
| 650 | 0 | |a Prostate-specific antigen. | |
| 650 | 1 | 2 | |a Prostatic Neoplasms |x diagnosis |
| 650 | 2 | 2 | |a Early Detection of Cancer |
| 650 | 2 | 2 | |a Patient Care Team |
| 650 | 2 | 2 | |a Prognosis |
| 650 | 2 | 2 | |a Prostate-Specific Antigen |
| 650 | 2 | 2 | |a Prostatic Neoplasms |x therapy |
| 650 | 6 | |a Prostate |x Cancer |x Traitement. | |
| 650 | 6 | |a Soins médicaux |x Travail en équipe. | |
| 650 | 6 | |a Pronostics (Pathologie) | |
| 650 | 6 | |a Antigène prostatique spécifique. | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x Cancer. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Oncology. |2 bisacsh | |
| 650 | 7 | |a Prostate-specific antigen |2 fast | |
| 650 | 7 | |a Prognosis |2 fast | |
| 650 | 7 | |a Health care teams |2 fast | |
| 650 | 7 | |a Prostate |x Cancer |x Diagnosis |2 fast | |
| 650 | 7 | |a Prostate |x Cancer |x Treatment |2 fast | |
| 700 | 1 | |a Dicker, Adam P., |e editor. | |
| 700 | 1 | |a Kelly, Wm. Kevin |q (William Kevin), |e editor. | |
| 700 | 1 | |a Zaorsky, Nicholas G., |e editor, |e illustrator. | |
| 700 | 1 | |a Trabulsi, Edouard J., |e editor. | |
| 776 | 0 | 8 | |i Print version: |t Prostate cancer. |d New York : Demos, [2015] |z 9781936287598 |w (DLC) 2014033133 |w (OCoLC)888347032 |
| 830 | 0 | |a Current multidisciplinary oncology. | |
| 856 | 4 | 0 | |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=933020 |z Texto completo |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH35067689 | ||
| 938 | |a EBL - Ebook Library |b EBLB |n EBL1910141 | ||
| 938 | |a ebrary |b EBRY |n ebr11012595 | ||
| 938 | |a EBSCOhost |b EBSC |n 933020 | ||
| 938 | |a YBP Library Services |b YANK |n 12224201 | ||
| 994 | |a 92 |b IZTAP | ||